Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 5;8(3):66.
doi: 10.3390/toxins8030066.

DNA Aptamers against Taiwan Banded Krait α-Bungarotoxin Recognize Taiwan Cobra Cardiotoxins

Affiliations

DNA Aptamers against Taiwan Banded Krait α-Bungarotoxin Recognize Taiwan Cobra Cardiotoxins

Ying-Jung Chen et al. Toxins (Basel). .

Abstract

Bungarus multicinctus α-bungarotoxin (α-Bgt) and Naja atra cardiotoxins (CTXs) share a common structural scaffold, and their tertiary structures adopt three-fingered loop motifs. Four DNA aptamers against α-Bgt have been reported previously. Given that the binding of aptamers with targeted proteins depends on structural complementarity, in this study, we investigated whether DNA aptamers against α-Bgt could also recognize CTXs. It was found that N. atra cardiotoxin 3 (CTX3) reduced the electrophoretic mobility of aptamers against α-Bgt. Analysis of the changes in the fluorescence intensity of carboxyfluorescein-labeled aptamers upon binding toxin molecules revealed that CTX3 and α-Bgt could bind the tested aptamers. Moreover, the aptamers inhibited the membrane-damaging activity and cytotoxicity of CTX3. In addition to CTX3, other N. atra CTX isotoxins also bound to the aptamer against α-Bgt. Taken together, our data indicate that aptamers against α-Bgt show cross-reactivity with CTXs. The findings that aptamers against α-Bgt also suppress the biological activities of CTX3 highlight the potential utility of aptamers in regard to the broad inhibition of snake venom three-fingered proteins.

Keywords: aptamer; cardiotoxins; cytotoxicity; membrane-damaging activity; α-bungarotoxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electrophoretic mobility shift assay of the binding of bgt1, bgt2, bgt3, and bgt4 aptamers to CTX3 and α-Bgt: 5 μM aptamers against α-Bgt was incubated with indicated concentrations of CTX3 and α-Bgt for 20 min, and then the aptamer-toxin mixtures were separated on 2% agarose gel.
Figure 2
Figure 2
Fluorescence spectra of FAM-bgt1-DABCYL and FAM-bgt1 in the presence of various CTX3 concentrations as indicated: (A) FAM-bgt1-DABCYL and (B) FAM-bgt1 in 10 mM Tris-HCl (pH 7.5) containing 1 mM EDTA and 100 mM NaCl were titrated with CTX3.
Figure 3
Figure 3
Effect of CTX3 and α-Bgt on fluorescence intensity of FAM-labeled bgt1, bgt2, bgt3, and bgt4 aptamers: the fluorescence intensity of FAM-labeled bgt1, bgt2, bgt3 and bgt4 was determined at 520 nm in the presence of various concentrations of (A) CTX3 or (B) α-Bgt. Fo and F represent the fluorescence intensity of FAM-labeled bgt1, bgt2, bgt3, and bgt4 in the absence and presence of toxins.
Figure 4
Figure 4
Effect of bgt1 (A), bgt2 (B), bgt3 (C), and bgt4 (D) aptamers on membrane-damaging activity of CTX3: CTX3 (0.23 μM) was incubated with 0.66, 1.65, and 3.30 μM aptamers against α-Bgt for 20 min, and then membrane-damaging activity of CTX3-aptamer mixtures were measured. Data represents mean ± SD of three independent experiments with triplicated measurements (* p < 0.05, vs. CTX3 without incubation with aptamers). The experiments were performed in 10 mM Tris-HCl (pH 7.5) containing 1 mM EDTA and 100 mM NaCl. The signal was expressed as the percentage of total calcein release after addition of 0.2% Triton X-100.
Figure 5
Figure 5
Effect of bgt1, bgt2, bgt3, and bgt4 aptamers on the cytotoxcity of CTX3: CTX3 (0.35 μM) was incubated with 1, 2, and 5 μM aptamers against α-Bgt for 20 min, and then the cytotoxicity of CTX3-aptamer mixtures were measured according to the procedure described in Materials and Methods section. Data represent mean ± SD of three independent experiments with triplicated measurements (* p < 0.05, vs. CTX3 without incubation with aptamers).
Figure 6
Figure 6
The fluorescence intensity of FAM-bgt1 in the presence of CTX isotoxins: (A) Fo and F represent the fluorescence intensity of FAM-bgt1 in the absence and presence of 1.5 μM CTXs. The fluorescence intensity was measured at 520 nm; and (B) amino acid sequence alignments of CTX1, CTX2, CTX3, CTX4, CTX5, CTXN, CLBP, and α-Bgt.

Similar articles

Cited by

References

    1. Keefe A.D., Pai S., Ellington A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 2010;9:537–550. doi: 10.1038/nrd3141. - DOI - PMC - PubMed
    1. Song K.M., Lee S., Ban C. Aptamers and their biological applications. Sensors. 2012;12:612–631. doi: 10.3390/s120100612. - DOI - PMC - PubMed
    1. Alvarenga L.M., Zahid M., di Tommaso A., Juste M.O., Aubrey N., Billiald P., Muzard J. Engineering venom’s toxin-neutralizing antibody fragments and its therapeutic potential. Toxins. 2014;6:2541–2567. doi: 10.3390/toxins6082541. - DOI - PMC - PubMed
    1. Morais V.M., Massaldi H. Snake antivenoms: Adverse reactions and production technology. J. Venom. Anim. Toxins Incl. Trop. Dis. 2009;15:2–18. doi: 10.1590/S1678-91992009000100002. - DOI
    1. Dart R.C., McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann. Emerg. Med. 2001;37:181–188. doi: 10.1067/mem.2001.113372. - DOI - PubMed

Publication types

LinkOut - more resources